The multifaceted mechanisms through which H+ modulates TRPV5 ion channel activity in bone cells in response to alterations in extracellular pH may offer promising opportunities for the innovation of drug delivery approaches and the identification of novel therapeutic targets for osteoporosis treatments. This evidence concerns the gene TRPV5 and osteoporosis.